首页>
外国专利>
CERVICAL CANCER-SPECIFIC METHYLATION MARKER FOR DIAGNOSING CERVICAL CANCER
CERVICAL CANCER-SPECIFIC METHYLATION MARKER FOR DIAGNOSING CERVICAL CANCER
展开▼
机译:诊断宫颈癌的宫颈癌甲基化标记
展开▼
页面导航
摘要
著录项
相似文献
摘要
PURPOSE: A cervical cancer-specific biomarker for diagnosing cervical cancer is provided to early diagnose cervical cancer and to accurately and quickly screen cervical cancer.;CONSTITUTION: A composition for diagnosing cervical cancer contains ASCC3(acyl-CoA synthetase short-chain family member 3, NM_024506,) gene promoter CpG island or gene UTR(Untranslated Region) region CpG island. The CpG island is placed ASCC3 gene promoter or UTR. A composition for diagnosing cervical cancer contains ADCYAP1(adenylate cyclase activating polypeptide 1, NM_001099733,) gene promoter or UTR, HOXA11(homeobox A11, NM_005523) gene promoter, or VIM(vimentin, NM_003380) gene promote CpG island. A method for detecting methylation of the biomarker ASCC3 gene comprises: a step of preparing a clinical sample containing DNA; and a step of detecting methylation of ASCC3 gene promoter CpG island or gene UTR site CpG island.;COPYRIGHT KIPO 2012
展开▼